ANDA 79061, held by Glenmark Pharmaceuticals. Alclometasone Dipropionate.
As of Nov 21, 2026, ANDA 79061 (Alclometasone Dipropionate), held by Glenmark Pharmaceuticals, was first approved by FDA on Jun 23, 2009, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 23, 2009 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Alclometasone Dipropionate0.05% · cream;topical | Alclometasone Dipropionate | Discontinued |
| Apr 17, 2014 | Supplement 3Labeling | Approved | None posted |
| Jun 23, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters